which cells produce insulin?
beta cells
modifiable CAD risk factors
mechanism of action of Sitagliptin
Blocks incretin breakdown via blocking DPP-4.
what is type 1 diabetes
Autoimmune beta cell destruction. So no insulin production to absorb excess glucose in blood which keeps blood glucose levels high. – Hyperglycaemia causes diabetic keto acidosis.
effects of insulin deficiency
mechanism of action of Exenatide
Mimics incretin, acts as an agonist on GLP-1 receptor.
complications of diabetes type 2 (both macro and micro)
Eyes (endothelial cells) à micro
Cataracts
Retinal microaneurysms & haemorrhage, exudation
Microaneurysms à first clinically recognisable feature of diabetic retinopathy. Balloon-like outpouchings/retinal perfusion.
First histopathological change seen in diabetic retinopathy à thickening of vascular basement membranes
Blood vessels à macro mainly
Atherosclerosis, thrombus, infection, gangrene
Neuropathy (Axonal loss, axonal regeneration, demyelination, Schwann cells & small nerves)
Cardiac autonomic neuropathy (CAN) à silent MI, arrhythmias & death
Kidneys à mirco mainly
b (mesangial cells)
mechanism of action of Sulfonylurea
Bind and inhibit SUR1 (K+ channel) on Beta-cells, causing increased depolarisation of Ca2+ à increased insulin release (it’s an insulin secretagogue)
Illness representations – 6 elements: